As of 2025-06-02, the Intrinsic Value of Nyfosa AB (NYF.ST) is 117.44 SEK. This NYF.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 87.10 SEK, the upside of Nyfosa AB is 34.80%.
The range of the Intrinsic Value is 64.45 - 225.32 SEK
Based on its market price of 87.10 SEK and our intrinsic valuation, Nyfosa AB (NYF.ST) is undervalued by 34.80%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 64.45 - 225.32 | 117.44 | 34.8% |
DCF (Growth 10y) | 91.45 - 272.15 | 151.20 | 73.6% |
DCF (EBITDA 5y) | 97.47 - 160.18 | 125.24 | 43.8% |
DCF (EBITDA 10y) | 120.06 - 207.91 | 158.32 | 81.8% |
Fair Value | 7.10 - 7.10 | 7.10 | -91.85% |
P/E | 18.88 - 53.96 | 24.19 | -72.2% |
EV/EBITDA | 91.85 - 148.20 | 114.37 | 31.3% |
EPV | 30.94 - 109.03 | 69.98 | -19.7% |
DDM - Stable | 9.48 - 20.15 | 14.81 | -83.0% |
DDM - Multi | 11.91 - 20.20 | 15.03 | -82.7% |
Market Cap (mil) | 18,125.51 |
Beta | 0.28 |
Outstanding shares (mil) | 208.10 |
Enterprise Value (mil) | 39,409.51 |
Market risk premium | 5.10% |
Cost of Equity | 6.51% |
Cost of Debt | 5.88% |
WACC | 5.83% |